These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 24261083)

  • 21. Proteomic differences between hepatocellular carcinoma and nontumorous liver tissue investigated by a combined gel-based and label-free quantitative proteomics study.
    Megger DA; Bracht T; Kohl M; Ahrens M; Naboulsi W; Weber F; Hoffmann AC; Stephan C; Kuhlmann K; Eisenacher M; Schlaak JF; Baba HA; Meyer HE; Sitek B
    Mol Cell Proteomics; 2013 Jul; 12(7):2006-20. PubMed ID: 23462207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A quantitative proteomic approach for identification of potential biomarkers in hepatocellular carcinoma.
    Chaerkady R; Harsha HC; Nalli A; Gucek M; Vivekanandan P; Akhtar J; Cole RN; Simmers J; Schulick RD; Singh S; Torbenson M; Pandey A; Thuluvath PJ
    J Proteome Res; 2008 Oct; 7(10):4289-98. PubMed ID: 18715028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two-dimensional electrophoresis map of the human hepatocellular carcinoma cell line, HCC-M, and identification of the separated proteins by mass spectrometry.
    Seow TK; Ong SE; Liang RC; Ren EC; Chan L; Ou K; Chung MC
    Electrophoresis; 2000 May; 21(9):1787-813. PubMed ID: 10870966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteomic identification of down-regulation of oncoprotein DJ-1 and proteasome activator subunit 1 in hepatitis B virus-infected well-differentiated hepatocellular carcinoma.
    Zhang D; Lim SG; Koay ES
    Int J Oncol; 2007 Sep; 31(3):577-84. PubMed ID: 17671684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative proteomic approach to understand metabolic adaptation in non-small cell lung cancer.
    Martín-Bernabé A; Cortés R; Lehmann SG; Seve M; Cascante M; Bourgoin-Voillard S
    J Proteome Res; 2014 Nov; 13(11):4695-704. PubMed ID: 25029028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Knockdown of Pokemon protein expression inhibits hepatocellular carcinoma cell proliferation by suppression of AKT activity.
    Zhu X; Dai Y; Chen Z; Xie J; Zeng W; Lin Y
    Oncol Res; 2013; 20(8):377-81. PubMed ID: 23924858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative Proteomic Analysis of Wild-Type and SAP Domain Mutant Foot-and-Mouth Disease Virus-Infected Porcine Cells Identifies the Ubiquitin-Activating Enzyme UBE1 Required for Virus Replication.
    Zhu Z; Yang F; Zhang K; Cao W; Jin Y; Wang G; Mao R; Li D; Guo J; Liu X; Zheng H
    J Proteome Res; 2015 Oct; 14(10):4194-206. PubMed ID: 26354183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel proteomic biomarker panel for prediction of aggressive metastatic hepatocellular carcinoma relapse in surgically resectable patients.
    Tan GS; Lim KH; Tan HT; Khoo ML; Tan SH; Toh HC; Ching Ming Chung M
    J Proteome Res; 2014 Nov; 13(11):4833-46. PubMed ID: 24946162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subcellular tissue proteomics of hepatocellular carcinoma for molecular signature discovery.
    Lee YY; McKinney KQ; Ghosh S; Iannitti DA; Martinie JB; Caballes FR; Russo MW; Ahrens WA; Lundgren DH; Han DK; Bonkovsky HL; Hwang SI
    J Proteome Res; 2011 Nov; 10(11):5070-83. PubMed ID: 21913717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of the C-Reactive Protein Interaction Network Using a Bioinformatics Approach Provides Insights into the Molecular Pathogenesis of Hepatocellular Carcinoma.
    She S; Jiang L; Zhang Z; Yang M; Hu H; Hu P; Liao Y; Yang Y; Ren H
    Cell Physiol Biochem; 2018; 48(2):741-752. PubMed ID: 30025407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative proteome analysis of ovarian cancer tissues using a iTRAQ approach.
    Wang LN; Tong SW; Hu HD; Ye F; Li SL; Ren H; Zhang DZ; Xiang R; Yang YX
    J Cell Biochem; 2012 Dec; 113(12):3762-72. PubMed ID: 22807371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteome analysis of human hepatocellular carcinoma tissues by two-dimensional difference gel electrophoresis and mass spectrometry.
    Liang CR; Leow CK; Neo JC; Tan GS; Lo SL; Lim JW; Seow TK; Lai PB; Chung MC
    Proteomics; 2005 May; 5(8):2258-71. PubMed ID: 15852300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative proteomics and molecular mechanical analysis in CDA-II induced therapy of LCI-D20 hepatocellular carcinoma model.
    Fan HZ; Liu H; Zhang C; Gao DM; Xue Q; Chen J; Sun RX; Liu YK; Yang PY
    J Cancer Res Clin Oncol; 2009 Apr; 135(4):591-602. PubMed ID: 18853186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioinformatics analysis of metastasis-related proteins in hepatocellular carcinoma.
    Song PM; Zhang Y; He YF; Bao HM; Luo JH; Liu YK; Yang PY; Chen X
    World J Gastroenterol; 2008 Oct; 14(38):5816-22. PubMed ID: 18855979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteomic analysis and molecular characterization of tissue ferritin light chain in hepatocellular carcinoma.
    Park KS; Kim H; Kim NG; Cho SY; Choi KH; Seong JK; Paik YK
    Hepatology; 2002 Jun; 35(6):1459-66. PubMed ID: 12029631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel quantitative proteomics workflow by isobaric terminal labeling.
    Yang SJ; Nie AY; Zhang L; Yan GQ; Yao J; Xie LQ; Lu HJ; Yang PY
    J Proteomics; 2012 Oct; 75(18):5797-806. PubMed ID: 22813877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy.
    Ding Y; Wang W; Feng M; Wang Y; Zhou J; Ding X; Zhou X; Liu C; Wang R; Zhang Q
    Biomaterials; 2012 Dec; 33(34):8893-905. PubMed ID: 22979990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection and identification of peroxiredoxin 3 as a biomarker in hepatocellular carcinoma by a proteomic approach.
    Qiao B; Wang J; Xie J; Niu Y; Ye S; Wan Q; Ye Q
    Int J Mol Med; 2012 May; 29(5):832-40. PubMed ID: 22344546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Global proteomic profiling in multistep hepatocarcinogenesis and identification of PARP1 as a novel molecular marker in hepatocellular carcinoma.
    Xu X; Liu Z; Wang J; Xie H; Li J; Cao J; Zhou L; Zheng S
    Oncotarget; 2016 Mar; 7(12):13730-41. PubMed ID: 26883192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteomic study of human hepatocellular carcinoma using two-dimensional difference gel electrophoresis with saturation cysteine dye.
    Fujii K; Kondo T; Yokoo H; Yamada T; Iwatsuki K; Hirohashi S
    Proteomics; 2005 Apr; 5(5):1411-22. PubMed ID: 15751005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.